5 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 2 Not applicable, 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Tryptamines: new trials by email Literature Review of Tryptamines trials Research Report on Tryptamines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey Rimegepant, Triptans - Migraine | Completed | Pfizer | 1395 | 2024-10-10 | 2026-01-22 | |
| Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP) Patients with migraine treated with triptans, Lasmiditan or Gepants - Migraine, Migraine Disorders | Unknown | Hospital Clínico Universitario de Valladolid | 1500 | 2023-12-04 | 2024-02-21 | |
| Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals Caffeine (200 mg), triptans, NSAID (Nonsteroidal anti-inflammatory drugs) - Migraine, Migraine Disease | Phase 4 | Recruiting | Ain Shams University | 120 | 2023-04-26 | 2025-06-15 |
| Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women Acute migraine treatment with any prescribed triptans, Standard of care management of acute migraine without triptans - Migraine, Cardiovascular Diseases | Completed | Mayo Clinic | 68419 | 2022-07-05 | 2024-12-02 | |
| Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine PFO closure device, Aspirin and clopidogrel, Triptans - PFO - Patent Foramen Ovale, Migraine | Phase 3 | Active not recruiting | Guangdong Provincial People's Hospital | 440 | 2021-08-12 | 2025-03-12 |
| Trip-Tox, Effectiveness of Triptans Before and After Onabotulinumtoxin A Treatment in Chronic Migraine OnabotulinumtoxinA - Chronic Migraine | Unknown | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 100 | 2021-03-25 | 2021-10-04 | |
| The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine Triptan, Doxycycline - Migraine Disorders, Headache, Migraine | Not applicable | Withdrawn | The Cleveland Clinic | 2012-07-01 | 2016-12-29 | |
| Clinical Effectiveness of Osteopathic Manipulative Treatment in Chronic Migraine osteopathic manipulative treatment, sham treatment, triptans - Migraine | Not applicable | Completed | European Institute for Evidence Based Osteopathic Medicine | 105 | 2010-03-01 | 2013-09-04 |
| Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response? Triptan, Treximet 85Mg-500Mg Tablet - Workplace Migraine Treatment | Phase 4 | Completed | The Cleveland Clinic | 60 | 2009-09-01 | 2018-05-01 |
| Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine Non-steroidal anti-inflammatory drug (NSAID), Triptan - Migraine Disorders | Completed | GlaxoSmithKline | 11249 | 2009-09-01 | 2017-05-16 |
Migraine Disorders (9) · Migraine with Aura (2) · Cardiovascular Diseases (1) · Foramen Ovale, Patent (1) · Headache (1) · Headache Disorders (1) · Headache Disorders, Primary (1) · Migraine without Aura (1)
The Cleveland Clinic (2) · Ain Shams University (1) · European Institute for Evidence Based Osteopathic Medicine (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · GlaxoSmithKline (1) · Guangdong Provincial People's Hospital (1) · Hospital Clínico Universitario de Valladolid (1) · Mayo Clinic (1) · Pfizer (1)
United States (4) · Spain (2) · China (1) · Egypt (1) · Italy (1)
Francesco Cerritelli, MS, DO (1) · Jennifer S Kriegler, MD (1) · Mohammad Murad, MD (1) · Shaheen E Lakhan, MD, PhD, MEd, MS (1)
PMID 19706829, PMID 21385086, PMID 25847552, PMID 30496104, PMID 38580946, PMID 39207344, PMID 40719668